Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Large-scale testing (Phase 3)UnknownNCT05751850
What this trial is testing

HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
First-line Treatment of Advanced Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 778
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698613
What this trial is testing

EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical ResectionPancreatic Cancer BorderlinePancreatic Cancer Resectable
Brown University 30
Early research (Phase 1)Ended earlyNCT06364696
What this trial is testing

Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

Who this might be right for
Solid Tumor
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Study completedNCT01693523
What this trial is testing

Minocycline Study in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 80
Not applicableStudy completedNCT02494037
What this trial is testing

The Canadian/US Integrative Oncology Study

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsPancreatic Neoplasms+1 more
The Canadian College of Naturopathic Medicine 400
Early research (Phase 1)Active Not RecruitingNCT00669734
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaPancreatic Acinar Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT04662112
What this trial is testing

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Asan Medical Center 40
Very early researchStudy completedNCT02847000
What this trial is testing

P53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Yogen Saunthararajah 13
Early research (Phase 1)Looking for participantsNCT05723107
What this trial is testing

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Cancer
NYU Langone Health 15
Testing effectiveness (Phase 2)Study completedNCT00102700
What this trial is testing

ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 66
Early research (Phase 1)Study completedNCT00614653
What this trial is testing

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 17
Early research (Phase 1)Ended earlyNCT04975256
What this trial is testing

Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplasm of Colon+2 more
Mirati Therapeutics Inc. 7
Early research (Phase 1)Study completedNCT04721301
What this trial is testing

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

Who this might be right for
Colorectal Cancer MetastaticPancreatic Cancer Metastatic
University Hospital Heidelberg 50
Not applicableEnded earlyNCT01683422
What this trial is testing

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Loma Linda University 9
Testing effectiveness (Phase 2)Study completedNCT04731467
What this trial is testing

CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more
Famewave Ltd. 79
Early research (Phase 1)Study completedNCT01385956
What this trial is testing

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03899636
What this trial is testing

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

Who this might be right for
Stage III Pancreatic Cancer
Angiodynamics, Inc. 528
Not applicableUnknownNCT00079365
What this trial is testing

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of South Florida
Early research (Phase 1)Study completedNCT03490669
What this trial is testing

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Who this might be right for
Advanced Solid TumorsPancreatic CancerNon Small Cell Lung Cancer+1 more
AstraZeneca 41
Next Page